GO | Name |
GO:0000122 | negative regulation of transcription by RNA polymerase II |
GO:0000785 | chromatin |
GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0001223 | transcription coactivator binding |
GO:0001227 | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO:0003677 | DNA binding |
GO:0003700 | DNA-binding transcription factor activity |
GO:0003707 | steroid hormone receptor activity |
GO:0004879 | nuclear receptor activity |
GO:0005634 | nucleus |
GO:0005654 | nucleoplasm |
GO:0006006 | glucose metabolic process |
GO:0006029 | proteoglycan metabolic process |
GO:0006091 | generation of precursor metabolites and energy |
GO:0006357 | regulation of transcription by RNA polymerase II |
GO:0006367 | transcription initiation from RNA polymerase II promoter |
GO:0006629 | lipid metabolic process |
GO:0006631 | fatty acid metabolic process |
GO:0006635 | fatty acid beta-oxidation |
GO:0006776 | vitamin A metabolic process |
GO:0006915 | apoptotic process |
GO:0007507 | heart development |
GO:0007566 | embryo implantation |
GO:0008134 | transcription factor binding |
GO:0008144 | drug binding |
GO:0008203 | cholesterol metabolic process |
GO:0008270 | zinc ion binding |
GO:0008283 | cell population proliferation |
GO:0008289 | lipid binding |
GO:0008366 | axon ensheathment |
GO:0008654 | phospholipid biosynthetic process |
GO:0009062 | fatty acid catabolic process |
GO:0009749 | response to glucose |
GO:0009755 | hormone-mediated signaling pathway |
GO:0010628 | positive regulation of gene expression |
GO:0010887 | negative regulation of cholesterol storage |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0014823 | response to activity |
GO:0014842 | regulation of skeletal muscle satellite cell proliferation |
GO:0014912 | negative regulation of smooth muscle cell migration |
GO:0015908 | fatty acid transport |
GO:0019216 | regulation of lipid metabolic process |
GO:0030154 | cell differentiation |
GO:0030308 | negative regulation of cell growth |
GO:0031589 | cell-substrate adhesion |
GO:0032966 | negative regulation of collagen biosynthetic process |
GO:0033189 | response to vitamin A |
GO:0033993 | response to lipid |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
GO:0042060 | wound healing |
GO:0043066 | negative regulation of apoptotic process |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration |
GO:0043616 | keratinocyte proliferation |
GO:0045600 | positive regulation of fat cell differentiation |
GO:0045662 | negative regulation of myoblast differentiation |
GO:0045684 | positive regulation of epidermis development |
GO:0045892 | negative regulation of transcription, DNA-templated |
GO:0045893 | positive regulation of transcription, DNA-templated |
GO:0045923 | positive regulation of fatty acid metabolic process |
GO:0045944 | positive regulation of transcription by RNA polymerase II |
GO:0046321 | positive regulation of fatty acid oxidation |
GO:0046697 | decidualization |
GO:0048662 | negative regulation of smooth muscle cell proliferation |
GO:0050680 | negative regulation of epithelial cell proliferation |
GO:0050728 | negative regulation of inflammatory response |
GO:0051059 | NF-kappaB binding |
GO:0051546 | keratinocyte migration |
GO:0060612 | adipose tissue development |
GO:0070539 | linoleic acid binding |
GO:0071222 | cellular response to lipopolysaccharide |
GO:0071456 | cellular response to hypoxia |
GO:0097190 | apoptotic signaling pathway |
GO:1902894 | negative regulation of pri-miRNA transcription by RNA polymerase II |
GO:1904659 | glucose transmembrane transport |
GO:1990837 | sequence-specific double-stranded DNA binding |
GO:2000288 | positive regulation of myoblast proliferation |